Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Novelion (NVLN.TO)
The ultimate 360° Tracker Your financial life in one place, automatically

Novelion (NVLN.TO)

0.00
-0.00 (0.00%)
52 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
DON'T BUY

Novelion(NVLN.TO)

Dec 14, 2000
Not enough products (2 only) A problem when you have competition.
Photo of David DriscollDavid DriscollUnlock Rating
$41.95

Stock price when the opinion was issued

biotechnologypharmaceutical
STRONG BUY

Novelion(NVLN.TO)

Dec 04, 2000
Likes. Visodine now being sold in US.
Photo of Steven WipperstegSteven WipperstegUnlock Rating
$69.00

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Novelion(NVLN.TO)

Dec 01, 2000
Client base may not be big enough for revenues needed. If you see a weak day, BUY
Photo of Richard StoneRichard StoneUnlock Rating
$74.30

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Nov 30, 2000
Excellent product, but will they have good sales and whats next in the product line?
Photo of Shauna SexsmithShauna SexsmithUnlock Rating
$67.85

Stock price when the opinion was issued

biotechnologypharmaceutical
STRONG BUY

Novelion(NVLN.TO)

Nov 29, 2000
Has been under a lot of pressure but a very good company. Stock is cheap right now
Photo of Pier DonniniPier DonniniUnlock Rating
$64.25

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Novelion(NVLN.TO)

Nov 28, 2000
Wouldn't buy until it gets to $55/60
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$68.00

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Nov 16, 2000
US now focusing on health care so should be good both short and long
Photo of Brendan KyneBrendan KyneUnlock Rating
$62.00

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Oct 18, 2000
On a roll now. Likes it
Photo of Michael SprungMichael SprungUnlock Rating
$85.00

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Oct 13, 2000
Likes company No competition. Good level to buy
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$81.00

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Oct 10, 2000
Cure for an eye problem. Not proven yet
Photo of Gordon Higgins, CA, MBAGordon Higgins, CA, MBAUnlock Rating
$76.00

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 181 to 190 of 190 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica